$62.40
0.19[0.31%]
Last update: 1:05PM Get Real Time Here
Bio-Techne
(NASDAQ:TECH)Latest News for Bio-Techne Stock (NASDAQ:TECH)
Bio-Techne Stock (NASDAQ: TECH)
Categories: All
Thursday, April 18, 2024
Monday, April 08, 2024
Thursday, March 28, 2024
Friday, March 22, 2024
Thursday, March 07, 2024
Monday, February 26, 2024
Friday, February 02, 2024
- Stephens & Co. Maintains Overweight on Bio-Techne, Lowers Price Target to $87Benzinga Newsdesk - Feb 2, 2024, 12:29PM
- Bio-Techne shares are trading lower after Stifel downgraded the stock from Buy to Hold and announced a $65 price target.Benzinga Newsdesk - Feb 2, 2024, 12:24PM
- RBC Capital Maintains Sector Perform Rating for Bio-Techne: Here's What You Need To KnowBenzinga Insights - Feb 2, 2024, 12:00PM
- RBC Capital Maintains Sector Perform on Bio-Techne, Lowers Price Target to $75Benzinga Newsdesk - Feb 2, 2024, 10:25AM
- Stifel Downgrades Bio-Techne to Hold, Announces $65 Price TargetBenzinga Newsdesk - Feb 2, 2024, 6:41AM
Thursday, February 01, 2024
- Bio-Techne shares are trading lower after the company reported worse-than-expected Q2 financial results.Benzinga Newsdesk - Feb 1, 2024, 10:53AM
- Bio-Techne Q2 Adj EPS $0.40 Misses $0.41 Estimate, Sales $272.60M Miss $277.53M EstimateBenzinga Newsdesk - Feb 1, 2024, 6:31AM
- Earnings Scheduled For February 1, 2024Benzinga Insights - Feb 1, 2024, 5:03AM
Wednesday, January 31, 2024
Friday, January 05, 2024
Wednesday, December 20, 2023
Thursday, December 07, 2023
Friday, November 24, 2023
Wednesday, November 01, 2023
- Citigroup Maintains Buy on Bio-Techne, Lowers Price Target to $80Benzinga Newsdesk - Nov 1, 2023, 4:13PM
- Stifel Maintains Buy on Bio-Techne, Lowers Price Target to $65Benzinga Newsdesk - Nov 1, 2023, 2:43PM
- RBC Capital Maintains Sector Perform on Bio-Techne, Lowers Price Target to $83Benzinga Newsdesk - Nov 1, 2023, 12:16PM
- Keybanc Maintains Overweight on Bio-Techne, Lowers Price Target to $80Benzinga Newsdesk - Nov 1, 2023, 5:52AM
Tuesday, October 31, 2023
- Bio-Techne Board Member Awarded $225K Worth of Stock OptionsBenzinga Insights - Oct 31, 2023, 11:00AM
- Board Member at Bio-Techne Acquires Company Stock Options Worth 3,937 SharesBenzinga Insights - Oct 31, 2023, 11:00AM
- Director at Bio-Techne Acquires Company Stock Options Worth 3,937 SharesBenzinga Insights - Oct 31, 2023, 11:00AM
- Bio-Techne Director Awarded $225K Worth of Stock OptionsBenzinga Insights - Oct 31, 2023, 11:00AM
- Bio-Techne Q1 Adjusted EPS $0.41 Misses $0.44 Estimate, Sales $276.94M Miss $287.77M EstimateBenzinga Newsdesk - Oct 31, 2023, 6:38AM
- Earnings Scheduled For October 31, 2023Benzinga Insights - Oct 31, 2023, 5:44AM
Monday, October 30, 2023
Monday, October 02, 2023
Tuesday, September 26, 2023
Tuesday, September 19, 2023
Thursday, September 14, 2023
Tuesday, September 12, 2023
Monday, August 28, 2023
- Life Science Firm Bio-Techne's Success Formula: Astute Acquisitions Offering TransformationVandana Singh - Aug 28, 2023, 4:09PM
- Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023Benzinga Insights - Aug 28, 2023, 11:00AM
- William Blair Initiates Coverage On Bio-Techne with Outperform RatingBenzinga Newsdesk - Aug 28, 2023, 9:31AM
Friday, August 18, 2023
Monday, August 14, 2023
Wednesday, August 09, 2023
Tuesday, August 08, 2023
- Nurturing Growth: Bio-Techne Supports Investors with Growing EarningsBenzinga Insights - Aug 8, 2023, 11:05AM
- Bio-Techne shares are trading higher after the company reported Q4 financial results.Benzinga Newsdesk - Aug 8, 2023, 10:57AM
- Bio-Techne Q4 Adjusted EPS $0.55, Inline, Sales $301.32M Miss $307.25M EstimateBenzinga Newsdesk - Aug 8, 2023, 6:31AM
- Earnings Scheduled For August 8, 2023Benzinga Insights - Aug 8, 2023, 4:48AM